Novo Nordisk has claimed
that new phase 3a findings have
shown a faster-acting insulin aspart
improved reduction in HbA1c in
type 1 diabetes, compared with its
own NovoRapid.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 14 Jun 16 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Jun 16
THE Pharmacy Guild of Australia has formally urged the Queensland government to establish a Pharmacy Council, with the move said to bring the state into line with all other Australian jurisdictions as well as “play an important role in bridging health gaps where pharmacies’ competencies could assist a health system under pressure”.